Recurrence Risk in CHD
To the Editor:
In their recent report concerning the recurrence risk in children having one parent with congenital heart disease, Nora and Nora' compared the observed risk in children with a predicted risk corresponding to the square root of an assumed population incidence for each defect. The consistently good or fair agreement between observed and expected risks was claimed to support the hypothesis that each type of CHD represented one genetic entity independent of other types and that the criteria for multifactorial inheritance according to a simplified mathematical model were satisfied. I think, however, that the presentation of data is somewhat misleading and also the approach unsuitable as a basis for the kind of multicenter cooperation which is necessary in this field because of the generally low risks.
First, the findings of defects similar and dissimilar to the index case should be presented separately. An observed risk for dissimilar defects of the same order as the population incidence would suggest that the increase in total risk for CHD is specific, as previously supposed by Nora.2 It would also serve as a test of the reliability of the study, as it is hard to believe that a heart defect in one individual should protect other family members from being affected with other types. A higher figure, on the other hand, would suggest a nonspecific increase in risk.
Secondly, the population incidence of each defect should be studied on a population basis rather than calculated by multiplying the relative frequency of each defect in hospital data by a rough estimate of 1% for the total population incidence of CHD irrespective of type. The latter method tends to give too high figures for those easily detected and diagnosed defects which are likely to come under medical care.
For example, the incidence of PDA is around 0.06% according to population studies from the USA and northwestern European countries.'' The square root of this is 2.4-2.5% and fits well with my own experience of the risk for PDA in children born to a parent with the same defect.8 After having excluded an expected number of dissimilar defects (3/490 or 0.6 ± 0.3%) and an equal number of PDAs of supposedly specific etiology, I found an observed risk of 12/484 or 2.5 ± 0.7% for isolated, nonsyndromic PDA. The corresponding incidence among the proband siblings was 2.3 + 0.6%. The heritability for children as estimated according to Falconer was 74 + 8%. These observations, the relations between sex and genetic risks, the frequency of concordance for monozygotic twins and available data on the occurrence of CHD among second degree relatives are best explained in terms of multifactorial inheritance.
Nora and Nora apparently assume a population incidence for PDA of 0.12%, the square root of which (or 3.5%) makes up their expectation figure for first degree relatives. An observed risk of the same order is attained by including cases belonging to other types as if they all represented PDA. Figures presented in this way cannot be used, alone or pooled with those from other studies, to elucidate the question about a possible increase in risk for other types. As already mentioned, my own data did not suggest any such increase as far as simple PDA is concerned. This gives further support to the view that nonsyndromic PDA is to be regarded as a clinical and genetic entity.
The above conclusions about PDA cannot be automatically applied to other types of CHD. Apart from a ductus which is unable to perform its last, self-destroying function, the different parts of the circulatory system are not independent of each other during formation, as they are functioning throughout this period and formation is influenced by normal and abnormal blood flow. Probably one of the best examples is the relationship between coarctation of the aorta and intracardiac defects.
When using my figures on coarctation, Nora and Nora did not mention that three out of five affected children had dissimilar defects. By so doing one may miss an essential point. An excess of left heart obstructions and VSDs among first degree relatives suggests the possibility that such intracardiac defects in the probandseven if insignificant in early postnatal lifemay have played an important part in the pathogenesis of the coarctation. The probable mechanism is a redistribution of flow in favor of the ductus at the expense of isthmus flow interacting as an internal environmental factor (or trigger) with a local predisposition for coarctation which may well be polygenic in nature.
Clustering of different cardiovascular malformations in one and the same family is known to occur' 7and has been the subject of a recent large-scale study.' The relationship between different types may be purely genetic or due to hemodynamic mechanisms during intrauterine life.
In ASD, which was the third type of CHD studied by me, the occurrence of simple dominant inheritance was evident,' and some data suggested the possibility of modified dominance in other families.5
In 1968 Nora2 wrote: "Perhaps no single misconception has more delayed an etiological understanding of congenital heart diseases than this; namely the assumption that a heterogenous category of anomalies could be approached as a single disease." This means that cases of different anatomical types should not be indiscriminately pooled in family studies. I find it equally important, however, to stress that, even within the frame of supposed multifactorial inheritanceor etiologyvarying types of CHD and the individual families cannot be supposed to conform with one and the same simple etiological model. In addition to single genes and external environmental factors the antenatal interplay between different parts of the heart and great vessels seems particularly worth of being considered.
